Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1995 | 06-1995 | 12-1994 | 06-1994 | 12-1993 | |
Sales | 0 | 6,277,772 | 4,453,125 | 4,322,866 | 3,990,000 |
Gross Profit | N/A | 6,277,772 | 4,453,125 | 4,322,866 | 3,990,000 |
Operating Income | N/A | 6,277,772 | 4,453,125 | 4,322,866 | 3,990,000 |
Pre-tax Income | 0 | 6,277,772 | 4,453,125 | 4,322,866 | 3,990,000 |
Net Income Continuous | N/A | 1,295,237 | 1,157,813 | 896,998 | 1,058,183 |
Net Income | $N/A | $1,295,237 | $1,157,813 | $896,998 | $1,058,183 |
EPS Basic Total Ops | N/A | 0.93 | 0.95 | 0.71 | 0.88 |
EPS Basic Continuous Ops | N/A | 0.93 | 0.95 | 0.71 | 0.88 |
EPS Diluted Total Ops | N/A | 0.93 | 0.95 | 0.71 | 0.88 |
EPS Diluted Continuous Ops | N/A | 0.93 | 0.95 | 0.71 | 0.88 |
EBITDA(a) | $N/A | $6,277,772 | $4,453,125 | $4,322,866 | $3,990,000 |